Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Treatment with Re-188 and I-131 remarkably inhibits mammary tumor growth
January 5th, 2006
According to recent research published in the journal Nuclear Medicine and Biology, treatment with rhenium-188-perrhenate ((ReO4-)-Re-118) and iodine-131 (I-131) of Na+/I- symporter (NIS)-expressing mammary cancer in a mouse model remarkably inhibits tumor growth. "Novel therapeutic modalities are needed for breast cancer patients in whom standard treatments are not effective. Mammary gland sodium/iodide symporter has been identified as a molecular target in breast cancers in humans and in some transgenic mouse models." "We report the results of a therapy study with I-131 and (ReO4-)-Re-118 of breast cancer in polyoma...
Source: Women's Health Weekly (2006-01-05)
|
